Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Trends in Molecular Medicine

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2017.09.001PMID 28993031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid

  2017cited by this paper
• Acetyl‐coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double‐blind, crossover study

  2017cited by this paper
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

  2017cited by this paper
• ATP-citrate lyase is essential for high glucose-induced histone hyperacetylation and fibrogenic gene upregulation in mesangial cells.

  2017cited by this paper
• Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

  2017cited by this paper
• Gut microbiome and liver disease.

  2017cited by this paper
• ACETYL-COA SYNTHETASE REGULATES HISTONE ACETYLATION AND HIPPOCAMPAL MEMORY

  2017cited by this paper
• Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.

  2017cited by this paper
• Cancer metabolism: a therapeutic perspective

  2017cited by this paper
• Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.

  2017cited by this paper
• Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to suppression of hepatic de novo lipogenesis and significant improvements in MRI-PDFF, MRE, and markers of fibrosis after 12 weeks of therapy in patients with NASH

  2017cited by this paper
• GENETIC TARGET VALIDATION FOR ATP-CITRATE LYASE INHIBITION

  2017cited by this paper
• Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

  2016cited by this paper
• Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes*

  2016cited by this paper
• Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis

  2016cited by this paper
• Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats

  2016cited by this paper
• Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation

  2016cited by this paper
• Knockdown of ATP citrate lyase in pancreatic beta cells does not inhibit insulin secretion or glucose flux and implicates the acetoacetate pathway in insulin secretion

  2016cited by this paper
• Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.

  2016cited by this paper
• Pathogenesis of Nonalcoholic Steatohepatitis.

  2016cited by this paper
• ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.

  2016cited by this paper
• Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease

  2016cited by this paper
• Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.

  2015cited by this paper
• High intensity interval training improves liver and adipose tissue insulin sensitivity

  2015cited by this paper
• ATP citrate lyase improves mitochondrial function in skeletal muscle.

  2015cited by this paper
• Ezetimibe added to statin therapy after acute coronary syndromes

  2015cited by this paper
• Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress

  2015cited by this paper
• Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

  2015cited by this paper
• IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease.

  2015cited by this paper
• Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.

  2015cited by this paper
• ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma.

  2015cited by this paper
• Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.

  2015cited by this paper
• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

  2015cited by this paper
• Acetyl-CoA and the Regulation of Metabolism: Mechanisms and Consequences

  2015cited by this paper
• Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.

  2014cited by this paper
• Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

  2014cited by this paper
• Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.

  2014cited by this paper
• Extrahepatic complications of nonalcoholic fatty liver disease

  2014cited by this paper
• Acetate dependence of tumors.

  2014cited by this paper
• Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus

  2014cited by this paper
• Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?

  2014cited by this paper
• Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

  2014cited by this paper
• Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.

  2013cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• NAFLD, NASH and liver cancer

  2013cited by this paper
• The global NAFLD epidemic

  2013cited by this paper
• AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism[S]

  2013cited by this paper
• SIRT1: Regulator of p53 Deacetylation.

  2013cited by this paper
• De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

  2013cited by this paper
• Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.

  2013cited by this paper
• Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.

  2013cited by this paper
• Updates on Antiobesity Effect of Garcinia Origin (−)-HCA

  2013cited by this paper
• DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.

  2013cited by this paper
• On the catalytic mechanism of human ATP citrate lyase.

  2012cited by this paper
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

  2012cited by this paper
• A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism

  2012cited by this paper
• Gene Expression in Livers of BALB/C and C57BL/6J Mice Fed a High-Fat Diet

  2012cited by this paper
• FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes

  2012cited by this paper
• Using multiple genetic variants as instrumental variables for modifiable risk factors

  2012cited by this paper
• The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.

  2012cited by this paper
• AMP-activated protein kinase: a target for drugs both ancient and modern

  2012cited by this paper
• AMP-activated protein kinase: new regulation, new roles?

  2012cited by this paper
• ETC-1002 LOWERS LDL-C AND BENEFICIALLY MODULATES OTHER CARDIO-METABOLIC RISK FACTORS IN HYPERCHOLESTEROLEMIC SUBJECTS WITH EITHER NORMAL OR ELEVATED TRIGLYCERIDES

  2012cited by this paper
• ATP-citrate lyase: a key player in cancer metabolism.

  2012cited by this paper
• Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival.

  2011cited by this paper
• Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment

  2011cited by this paper
• On acetyl-CoA as a gauge of cellular metabolic state.

  2011cited by this paper
• Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

  2011cited by this paper
• Human Fatty Liver Disease: Old Questions and New Insights

  2011cited by this paper
• Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.

  2011cited by this paper
• Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

  2011cited by this paper
• A position statement on NAFLD/NASH based on the EASL 2009 special conference.

  2010cited by this paper
• Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography*

  2010cited by this paper
• Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

  2010cited by this paper
• Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

  2010cited by this paper
• Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility

  2010cited by this paper
• The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

  2010cited by this paper
• AMPK inhibition in health and disease

  2010cited by this paper
• Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation

  2010cited by this paper
• ATP-Citrate Lyase Reduction Mediates Palmitate-induced Apoptosis in Pancreatic Beta Cells*

  2010cited by this paper
• Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

  2010cited by this paper
• The nuclear pore complex and nuclear transport.

  2010cited by this paper
• SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310

  2010cited by this paper
• Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

  2010cited by this paper
• Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1

  2010cited by this paper
• Abrogation of hepatic ATP‐citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor‐deficient mice

  2009cited by this paper
• Hepatic triacylglycerol accumulation and insulin resistance This work was supported by National Institutes of Health Grants DK56598, DK59935, and DK56350. Published, JLR Papers in Press, November 6, 2008.

  2009cited by this paper
• Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats.

  2009cited by this paper
• ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

  2009cited by this paper
• AMPK in Health and Disease.

  2009cited by this paper
• The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α

  2008cited by this paper
• Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome.

  2008cited by this paper
• ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.

  2008cited by this paper
• Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.

  2008cited by this paper
• Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase

  2008cited by this paper
• Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women

  2008cited by this paper
• Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.

  2008cited by this paper

• Bempedoic acid directly binds and activates PPARα.

  2026cites this paper
• Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis

  2025cites this paper
• A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY

  2025cites this paper
• Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm.

  2025cites this paper
• Protein succinylome analysis identifies citrate synthase as a central regulator of osteoclast metabolic activity

  2025cites this paper
• Genetic insights support PARP1 as a mediator in the protective association of ATP-citrate lyase inhibitors with melanoma

  2025cites this paper
• Interleukin-1 Receptor Antagonist as a Potential Mediator Linking Psoriasis and Non-Alcoholic Fatty Liver Disease: Insights From Mendelian Randomization and Experimental Evidence

  2025cites this paper
• TCA-cycle metabolites in the nucleus: drivers of chromatin and epigenetic control

  2025cites this paper
• The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPARα.

  2025cites this paper
• Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial.

  2025cites this paper
• Effect of free fatty acids on TGF-β1 mediated fibrogenesis in hepatic stellate cells

  2025cites this paper
• The protein denitrosylase SCoR2 regulates lipogenesis and fat storage.

  2025cites this paper
• ATP-Citrate Lyase Supports Cardiac Function and NAD+/NADH Balance and Is Depressed in Human Failing Myocardium

  2025cites this paper
• Metformin-mediated protection against Immunosenescence in diabetic cardiomyopathy: The potential roles of GDF-15 and klotho proteins.

  2025cites this paper
• Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence

  2025cites this paper
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects

  2025cites this paper
• Nanozyme as a rising star for metabolic disease management

  2024cites this paper
• Phytochemical Composition and Antioxidant Properties of Avocado (Persea americana) Seed Extract from Aceh, Indonesia: Implications for Antihyperlipidemic Use in Postmenopausal Women

  2024cites this paper
• Discovery of Alkyl Conjugated Diene Diacids as Novel ACLY Inhibitors

  2024cites this paper
• Molecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases.

  2024cites this paper
• Ubiquitination and Metabolic Disease.

  2024cites this paper
• 40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model

  2024cites this paper
• Nuclear membrane: A key potential therapeutic target for lipid metabolism.

  2024cites this paper
• LXR-dependent enhancer activation regulates the temporal organization of the liver’s response to refeeding leading to lipogenic gene overshoot

  2024cites this paper
• Aberrant mitochondrial DNA synthesis in macrophages exacerbates inflammation and atherosclerosis

  2024cites this paper
• Effects of ACLY Inhibition on Body Weight Distribution: A Drug Target Mendelian Randomization Study

  2024cites this paper
• Catalytic mechanism study of ATP-citrate lyase during citryl-CoA synthesis process

  2024cites this paper
• Atherosclerosis and inflammation: therapeutic targets and ways of correction

  2024cites this paper
• The 40 Hz flickering light restores synaptic plasticity and mitochondrial phenotype in experimental model of Alzheimer’s disease

  2024cites this paper
• Pentacyclic triterpenoids as potential ACL inhibitors from the rare medicinal plant Semiliquidambar cathayensis.

  2024cites this paper
• The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases.

  2024cites this paper
• DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER

  2024cites this paper
• Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery.

  2023cites this paper
• Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials

  2023cites this paper
• In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions

  2023cites this paper
• Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance.

  2023cites this paper
• Transflammation in Tissue Regeneration and Response to Injury How cell-autonomous inflammatory signaling mediates cell plasticity.

  2023cites this paper
• Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent

  2023cites this paper
• Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects.

  2023cites this paper
• Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis

  2023cites this paper
• Forrestiacids E-K: Further [4 + 2]-Type Triterpene-Diterpene Hybrids as Potential ACL Inhibitors from the Vulnerable Conifer Pseudotsuga forrestii.

  2023cites this paper
• Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside

  2023cites this paper
• AMPK and the Endocrine Control of Metabolism.

  2023cites this paper
• Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action

  2023cites this paper
• Potential of Caffeic Acid and 10-Dehydrogingerdione as Lipid Regulators Relevant to Their Inhibitory Effect on miR-122 and ATP Citrate Lyase Activity in Diabetic Hyperlipidemic Rats

  2023cites this paper
• Limiting Mrs2-dependent mitochondrial Mg2+ uptake induces metabolic programming in prolonged dietary stress

  2023cites this paper
• Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances.

  2023cites this paper
• The Pathogenetic Basis of the Action of Bempedoic Acid

  2023cites this paper
• Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease

  2022cites this paper
• Lipogenesis inhibitors: therapeutic opportunities and challenges

  2022cites this paper
• Effects of magnesium picolinate, zinc picolinate, and selenomethionine co-supplementation on reproductive hormones, and glucose and lipid metabolism-related protein expressions in male rats fed a high-fat diet

  2022cites this paper
• Structurally diverse glycosides of secoiridoid, bisiridoid, and triterpene-bisiridoid conjugates from the flower buds of two Caprifoliaceae plants and their ATP-citrate lyase inhibitory activities.

  2022cites this paper
• 53BP1-ACLY-SLBP-coordinated activation of replication-dependent histone biogenesis maintains genomic integrity

  2022cites this paper
• Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental model

  2022cites this paper
• ATP-citrate lyase and chronic kidney disease: a Mendelian Randomization analysis

  2022cites this paper
• Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia.

  2022cites this paper
• Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor

  2022cites this paper
• Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia

  2022cites this paper
• Investigation into potential mechanisms of metabolic syndrome by integrative analysis of metabolomics and proteomics

  2022cites this paper
• ACLY and CKD: A Mendelian Randomization Analysis

  2022cites this paper
• ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model

  2022cites this paper
• Preparation and identification of isoquinoline alkaloids with ATP citrate lyase inhibitory activity from Dactylicapnos scandens.

  2022cites this paper
• Exploring the Role of ATP-Citrate Lyase in the Immune System

  2021cites this paper
• Bempedoic acid as a PPARα activator: new perspectives for hepatic steatosis treatment in a female rat experimental model.

  2021cites this paper
• ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score

  2021cites this paper
• The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.

  2021cites this paper
• ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis

  2021cites this paper
• Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes

  2021cites this paper
• Forrestiacids A and B, Pentaterpene Inhibitors of ACL and Lipogenesis: Extending the limits of Computational NMR Methods in the Structure Assignment of Complex Natural Products.

  2021cites this paper
• Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase

  2021cites this paper
• Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation

  2021cites this paper
• Role of Bempedoic Acid in Clinical Practice

  2021cites this paper
• Adipocyte ACLY Facilitates Dietary Carbohydrate Handling to Adipocyte ACLY Facilitates Dietary Carbohydrate Handling to Maintain Metabolic Homeostasis in Females Maintain Metabolic Homeostasis in Females

  2021cites this paper
• Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion.

  2021cites this paper
• Multi-organ proteomic landscape of COVID-19 autopsies

  2020cites this paper
• Defining the role of bempedoic acid in lowering low-density lipoprotein cholesterol

  2020cites this paper
• Effect of bempedoic acid onnew onset or worseningdiabetes: a meta-analysis.

  2020cites this paper
• Statins plus ezetimibe in the era of proprotein convertase subtilisin/kexin type-9 inhibitors.

  2020cites this paper
• Clinical Pharmacology of Statins: an Update

  2020cites this paper
• Clinical approach to the inflammatory etiology of cardiovascular diseases

  2020cites this paper
• Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice.

  2020cites this paper
• Stewartiacids A–N, C-23 carboxylated triterpenoids from Chinese Stewartia and their inhibitory effects against ATP-citrate lyase and NF-κB

  2020cites this paper
• Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate

  2020cites this paper
• Therapeutic landscape for NAFLD in 2020.

  2020cites this paper
• In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis

  2020cites this paper
• Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study

  2020cites this paper
• Phytochemical and biological studies on rare and endangered plants endemic to China. Part XV. Structurally diverse diterpenoids and sesquiterpenoids from the vulnerable conifer Pseudotsuga sinensis.

  2020cites this paper
• The vital role of ATP citrate lyase in chronic diseases

  2019influential citation
• The molecular basis for current targets of NASH therapies

  2019cites this paper
• ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis

  2019cites this paper
• ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials

  2019cites this paper
• Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions

  2019cites this paper
• Regulated Acyl-CoA Synthetase Short-Chain Family Member 2 Accumulation during Spermatogenesis

  2019cites this paper
• Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis

  2019cites this paper
• ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.

  2019cites this paper
• Structure of the human ATP citrate lyase holoenzyme in complex with citrate, coenzyme A and Mg.ADP

  2019cites this paper
• A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology

  2019cites this paper
• ATP‐citrate lyase is an epigenetic regulator to promote obesity‐related kidney injury

  2019influential citation
• Adipocyte ACLY Facilitates Dietary Carbohydrate Handling to Maintain Metabolic Homeostasis in Females

  2019cites this paper
• Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle

  2019cites this paper